A STUDY OF ABIRATERONE ACETATE PLUS PREDNISONE WITH OR WITHOUT EXEMESTANE IN POSTMENOPAUSAL WOMEN WITH ESTROGEN RECEPTOR-POSITIVE (ER+) METASTATIC BREAST CANCER PROGRESSING AFTER LETROZOLE OR ANASTROZOLE THERAPY: